Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06474468
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-06
Brief Title:
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Sponsor:
Shanghai Hengrui Pharmaceutical Co Ltd
Organization:
Shanghai Hengrui Pharmaceutical Co Ltd
Organization Data
Organization:
Shanghai Hengrui Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
SHR-A2102-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None